Curated Resources — Long term outcome of Gastroparesis after Ozempic

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

In-depth resource

Long term outcome of Gastroparesis after Ozempic — Background & Analysis

In-depth context and analysis on this topic for researchers and advocates.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.